USBC

SEC source: 0001161697-26-000233 · form4.xml · derivative · entry 2

PAYNE KITTY B · CIK 0001250826 · Former CFO, Treasurer, Secret.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 490,000

Underlying: Common Stock · 1,470,000 shares

Expires 2026-11-30

F2 · security: On October 1, 2026, the Board of Directors of the Company approved the acceleration of the vesting of 490,000 options originally granted to the Reporting Person on October 7, 2025, from October 6, 2026 to September 1, 2026. In connection with the Reporting Person's transition from the Company, 1,470,000 unvested options were forfeited. Following the transaction reported herein, the Reporting Person continues to hold 490,000 options, which became exercisable as of September 1, 2026 as a result of the acceleration.

F2 · kind: On October 1, 2026, the Board of Directors of the Company approved the acceleration of the vesting of 490,000 options originally granted to the Reporting Person on October 7, 2025, from October 6, 2026 to September 1, 2026. In connection with the Reporting Person's transition from the Company, 1,470,000 unvested options were forfeited. Following the transaction reported herein, the Reporting Person continues to hold 490,000 options, which became exercisable as of September 1, 2026 as a result of the acceleration.

F2 · derivative.exercise_date: On October 1, 2026, the Board of Directors of the Company approved the acceleration of the vesting of 490,000 options originally granted to the Reporting Person on October 7, 2025, from October 6, 2026 to September 1, 2026. In connection with the Reporting Person's transition from the Company, 1,470,000 unvested options were forfeited. Following the transaction reported herein, the Reporting Person continues to hold 490,000 options, which became exercisable as of September 1, 2026 as a result of the acceleration.

F2 · balance_after: On October 1, 2026, the Board of Directors of the Company approved the acceleration of the vesting of 490,000 options originally granted to the Reporting Person on October 7, 2025, from October 6, 2026 to September 1, 2026. In connection with the Reporting Person's transition from the Company, 1,470,000 unvested options were forfeited. Following the transaction reported herein, the Reporting Person continues to hold 490,000 options, which became exercisable as of September 1, 2026 as a result of the acceleration.

SEC source: 0001161697-26-000233 · form4.xml · derivative · entry 1

PAYNE KITTY B · CIK 0001250826 · Former CFO, Treasurer, Secret.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 447,500

Underlying: Common Stock · 1,342,500 shares

Expires 2026-11-30

F1 · security: The options reported reflect options originally granted to the Reporting Person on August 6, 2025. In connection with the Reporting Person's transition from the Company, 1,342,500 unvested options were forfeited. Following the transaction reported herein, the Reporting Person continues to hold 447,500 options, which became exercisable on August 6, 2026 in accordance with the original vesting schedule.

F1 · kind: The options reported reflect options originally granted to the Reporting Person on August 6, 2025. In connection with the Reporting Person's transition from the Company, 1,342,500 unvested options were forfeited. Following the transaction reported herein, the Reporting Person continues to hold 447,500 options, which became exercisable on August 6, 2026 in accordance with the original vesting schedule.

F1 · derivative.exercise_date: The options reported reflect options originally granted to the Reporting Person on August 6, 2025. In connection with the Reporting Person's transition from the Company, 1,342,500 unvested options were forfeited. Following the transaction reported herein, the Reporting Person continues to hold 447,500 options, which became exercisable on August 6, 2026 in accordance with the original vesting schedule.

F1 · balance_after: The options reported reflect options originally granted to the Reporting Person on August 6, 2025. In connection with the Reporting Person's transition from the Company, 1,342,500 unvested options were forfeited. Following the transaction reported herein, the Reporting Person continues to hold 447,500 options, which became exercisable on August 6, 2026 in accordance with the original vesting schedule.

SEC source: 0001161697-26-000232 · form4.xml · derivative · entry 1

Beck Daniel J · CIK 0001708156 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,500,000

Underlying: Common Stock · 2,500,000 shares

Expires 2036-10-01

F1 · security: On October 1, 2026 (the "Grant Date"), the Reporting Person was granted an option to purchase 2,500,000 shares of the Issuer's common stock pursuant to the Issuer's 2021 Equity Incentive Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

F1 · kind: On October 1, 2026 (the "Grant Date"), the Reporting Person was granted an option to purchase 2,500,000 shares of the Issuer's common stock pursuant to the Issuer's 2021 Equity Incentive Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

F1 · derivative.exercise_date: On October 1, 2026 (the "Grant Date"), the Reporting Person was granted an option to purchase 2,500,000 shares of the Issuer's common stock pursuant to the Issuer's 2021 Equity Incentive Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

SEC source: 0001161697-26-000206 · form4.xml · derivative · entry 2

OWENS WILLIAM ARTHUR · CIK 0001184212 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2036-08-12

F1 · derivative.exercise_date: On August 12, 2026 (the "Grant Date"), the Reporting Person was granted an option to purchase 120,000 shares of the Issuer's common stock pursuant to the Issuer's Amended and Restated 2021 Equity Incentive Plan. The option vest as to 10,000 shares on September 30, 2026 and in eleven quarterly installments of 10,000 shares thereafter through June 30, 2029.

SEC source: 0001161697-26-000208 · form_4.xml · derivative · entry 2

Takesako Ichiro · CIK 0001572834 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2036-08-12

F1 · derivative.exercise_date: On August 12, 2026 (the "Grant Date"), the Reporting Person was granted an option to purchase 120,000 shares of the Issuer's common stock pursuant to the Issuer's Amended and Restated 2021 Equity Incentive Plan. The option vest as to 10,000 shares on September 30, 2026 and in eleven quarterly installments of 10,000 shares thereafter through June 30, 2029.

SEC source: 0001161697-26-000207 · form_4.xml · derivative · entry 2

PEPPER JON · CIK 0001484963 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2036-08-12

F1 · derivative.exercise_date: On August 12, 2026 (the "Grant Date"), the Reporting Person was granted an option to purchase 120,000 shares of the Issuer's common stock pursuant to the Issuer's Amended and Restated 2021 Equity Incentive Plan. The option vest as to 10,000 shares on September 30, 2026 and in eleven quarterly installments of 10,000 shares thereafter through June 30, 2029.

SEC source: 0001161697-26-000205 · form4.xml · derivative · entry 2

Ellingson Larry K · CIK 0002000560 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2036-08-12

F1 · derivative.exercise_date: On August 12, 2026 (the "Grant Date"), the Reporting Person was granted an option to purchase 120,000 shares of the Issuer's common stock pursuant to the Issuer's Amended and Restated 2021 Equity Incentive Plan. The option vest as to 10,000 shares on September 30, 2026 and in eleven quarterly installments of 10,000 shares thereafter through June 30, 2029.

SEC source: 0001161697-26-000071 · form4.xml · derivative · entry 2

Jenkinson Linda · CIK 0002081130 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000,000

Underlying: Common Stock · 10,000,000 shares

Expires 2036-03-18

F2 · security: On March 18, 2026, in accordance with the terms of the Amended and Restated 2021 Plan, the Board of Directors of the Company approved a repricing of outstanding stock options granted or repriced on October 7, 2025. The exercise price of each repriced option was reduced from $1.10 to $0.37 per share. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

F2 · derivative.exercise_date: On March 18, 2026, in accordance with the terms of the Amended and Restated 2021 Plan, the Board of Directors of the Company approved a repricing of outstanding stock options granted or repriced on October 7, 2025. The exercise price of each repriced option was reduced from $1.10 to $0.37 per share. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

SEC source: 0001161697-26-000071 · form4.xml · derivative · entry 1

Jenkinson Linda · CIK 0002081130 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000,000 shares

Expires 2035-10-07

F1 · security: The transactions reported involved the repricing of outstanding stock options to purchase 10,000,000 shares of common stock of USBC, Inc. (the "Company") pursuant to the Amended and Restated USBC, Inc. 2021 Equity Incentive Plan (the "Amended and Restated 2021 Plan"), reflecting the options granted on August 6 and October 7, 2025. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of their respective grant dates and in quarterly installments thereafter over the next three years.

F1 · derivative.exercise_date: The transactions reported involved the repricing of outstanding stock options to purchase 10,000,000 shares of common stock of USBC, Inc. (the "Company") pursuant to the Amended and Restated USBC, Inc. 2021 Equity Incentive Plan (the "Amended and Restated 2021 Plan"), reflecting the options granted on August 6 and October 7, 2025. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of their respective grant dates and in quarterly installments thereafter over the next three years.

SEC source: 0001161697-26-000069 · form4.xml · derivative · entry 2

PAYNE KITTY B · CIK 0001250826 · CFO, Treasurer, Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,750,000

Underlying: Common Stock · 3,750,000 shares

Expires 2036-03-18

F2 · security: On March 18, 2026, in accordance with the terms of the Amended and Restated 2021 Plan, the Board of Directors of the Company approved a repricing of outstanding stock options granted or repriced on October 7, 2025. The exercise price of each repriced option was reduced from $1.10 to $0.37 per share. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

F2 · derivative.exercise_date: On March 18, 2026, in accordance with the terms of the Amended and Restated 2021 Plan, the Board of Directors of the Company approved a repricing of outstanding stock options granted or repriced on October 7, 2025. The exercise price of each repriced option was reduced from $1.10 to $0.37 per share. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

SEC source: 0001161697-26-000069 · form4.xml · derivative · entry 1

PAYNE KITTY B · CIK 0001250826 · CFO, Treasurer, Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,750,000 shares

Expires 2035-10-07

F1 · security: The transactions reported involved the repricing of outstanding stock options to purchase 3,750,000 shares of common stock of USBC, Inc. (the "Company") pursuant to the Amended and Restated USBC, Inc. 2021 Equity Incentive Plan (the "Amended and Restated 2021 Plan"), reflecting the options granted on August 6 and October 7, 2025. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of their respective grant dates and in quarterly installments thereafter over the next three years.

F1 · derivative.exercise_date: The transactions reported involved the repricing of outstanding stock options to purchase 3,750,000 shares of common stock of USBC, Inc. (the "Company") pursuant to the Amended and Restated USBC, Inc. 2021 Equity Incentive Plan (the "Amended and Restated 2021 Plan"), reflecting the options granted on August 6 and October 7, 2025. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of their respective grant dates and in quarterly installments thereafter over the next three years.

SEC source: 0001161697-25-000360 · form4.xml · derivative · entry 3

PAYNE KITTY B · CIK 0001250826 · CFO, Treasurer, Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,750,000

Underlying: Common Stock · 1,960,000 shares

Expires 2035-10-07

F3 · security: On October 7, 2025, the Reporting Person was granted an option to purchase 1,960,000 shares of the Company's common stock pursuant to the Amended and Restated 2021 Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

F3 · derivative.exercise_date: On October 7, 2025, the Reporting Person was granted an option to purchase 1,960,000 shares of the Company's common stock pursuant to the Amended and Restated 2021 Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

SEC source: 0001161697-25-000360 · form4.xml · derivative · entry 2

PAYNE KITTY B · CIK 0001250826 · CFO, Treasurer, Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,790,000

Underlying: Common Stock · 1,790,000 shares

Expires 2035-10-07

F2 · security: On October 7, 2025, in accordance with the terms of the Amended and Restated 2021 Plan, the Board of Directors of the Company approved a repricing of outstanding stock options granted on August 6, 2025. The exercise price of each repriced option was reduced from $2.45 to $1.10 per share.

F2 · derivative.exercise_date: On October 7, 2025, in accordance with the terms of the Amended and Restated 2021 Plan, the Board of Directors of the Company approved a repricing of outstanding stock options granted on August 6, 2025. The exercise price of each repriced option was reduced from $2.45 to $1.10 per share.

SEC source: 0001161697-25-000360 · form4.xml · derivative · entry 1

PAYNE KITTY B · CIK 0001250826 · CFO, Treasurer, Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,790,000 shares

Expires 2035-08-06

F1 · security: The transactions reported involved the repricing of outstanding stock options to purchase 1,790,000 shares of common stock of USBC, Inc. (the "Company") pursuant to the Amended and Restated USBC, Inc. 2021 Equity Incentive Plan (the "Amended and Restated 2021 Plan"), initially granted on August 6, 2025 (the "Grant Date"). The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

F1 · derivative.exercise_date: The transactions reported involved the repricing of outstanding stock options to purchase 1,790,000 shares of common stock of USBC, Inc. (the "Company") pursuant to the Amended and Restated USBC, Inc. 2021 Equity Incentive Plan (the "Amended and Restated 2021 Plan"), initially granted on August 6, 2025 (the "Grant Date"). The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

SEC source: 0001161697-25-000359 · form4.xml · derivative · entry 3

Jenkinson Linda · CIK 0002081130 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000,000

Underlying: Common Stock · 5,240,000 shares

Expires 2035-10-07

F3 · security: On October 7, 2025, the Reporting Person was granted an option to purchase 5,240,000 shares of the Company's common stock pursuant to the Amended and Restated 2021 Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

F3 · derivative.exercise_date: On October 7, 2025, the Reporting Person was granted an option to purchase 5,240,000 shares of the Company's common stock pursuant to the Amended and Restated 2021 Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

SEC source: 0001161697-25-000359 · form4.xml · derivative · entry 2

Jenkinson Linda · CIK 0002081130 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,760,000

Underlying: Common Stock · 4,760,000 shares

Expires 2035-10-07

F2 · security: On October 7, 2025, in accordance with the terms of the Amended and Restated 2021 Plan, the Board of Directors of the Company approved a repricing of outstanding stock options granted on August 6, 2025. The exercise price of each repriced option was reduced from $2.45 to $1.10 per share.

F2 · derivative.exercise_date: On October 7, 2025, in accordance with the terms of the Amended and Restated 2021 Plan, the Board of Directors of the Company approved a repricing of outstanding stock options granted on August 6, 2025. The exercise price of each repriced option was reduced from $2.45 to $1.10 per share.

SEC source: 0001161697-25-000359 · form4.xml · derivative · entry 1

Jenkinson Linda · CIK 0002081130 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,760,000 shares

Expires 2035-08-06

F1 · security: The transactions reported involved the repricing of outstanding stock options to purchase 4,760,000 shares of common stock of USBC, Inc. (the "Company") pursuant to the Amended and Restated USBC, Inc. 2021 Equity Incentive Plan (the "Amended and Restated 2021 Plan"), initially granted on August 6, 2025 (the "Grant Date"). The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

F1 · derivative.exercise_date: The transactions reported involved the repricing of outstanding stock options to purchase 4,760,000 shares of common stock of USBC, Inc. (the "Company") pursuant to the Amended and Restated USBC, Inc. 2021 Equity Incentive Plan (the "Amended and Restated 2021 Plan"), initially granted on August 6, 2025 (the "Grant Date"). The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

SEC source: 0001161697-25-000358 · form4.xml · derivative · entry 3

Chapman Kirk · CIK 0002080978 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000,000

Underlying: Common Stock · 7,860,000 shares

Expires 2035-10-07

F3 · security: On October 7, 2025, the Reporting Person was granted an option to purchase 7,860,000 shares of the Issuer's common stock pursuant to the Amended and Restated 2021 Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

F3 · derivative.exercise_date: On October 7, 2025, the Reporting Person was granted an option to purchase 7,860,000 shares of the Issuer's common stock pursuant to the Amended and Restated 2021 Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

SEC source: 0001161697-25-000358 · form4.xml · derivative · entry 2

Chapman Kirk · CIK 0002080978 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,140,000

Underlying: Common Stock · 7,140,000 shares

Expires 2035-10-07

F2 · security: On October 7, 2025, in accordance with the terms of the Amended and Restated 2021 Plan, the Board of Directors the Company approved a repricing of outstanding stock options granted on August 6, 2025. The exercise price of each repriced option was reduced from $2.45 to $1.10 per share.

F2 · derivative.exercise_date: On October 7, 2025, in accordance with the terms of the Amended and Restated 2021 Plan, the Board of Directors the Company approved a repricing of outstanding stock options granted on August 6, 2025. The exercise price of each repriced option was reduced from $2.45 to $1.10 per share.

SEC source: 0001161697-25-000358 · form4.xml · derivative · entry 1

Chapman Kirk · CIK 0002080978 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,140,000 shares

Expires 2035-08-06

F1 · security: The transactions reported involved the repricing of outstanding stock options to purchase 7,140,000 shares of common stock of USBC, Inc. (the "Company") pursuant to the Amended and Restated USBC, Inc. 2021 Equity Incentive Plan (the "Amended and Restated 2021 Plan"), initially granted on August 6, 2025 (the "Grant Date"). The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

F1 · derivative.exercise_date: The transactions reported involved the repricing of outstanding stock options to purchase 7,140,000 shares of common stock of USBC, Inc. (the "Company") pursuant to the Amended and Restated USBC, Inc. 2021 Equity Incentive Plan (the "Amended and Restated 2021 Plan"), initially granted on August 6, 2025 (the "Grant Date"). The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

SEC source: 0001161697-25-000234 · form4.xml · derivative · entry 1

PAYNE KITTY B · CIK 0001250826 · CFO, Treasurer, Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,790,000

Underlying: Common Stock · 1,790,000 shares

Expires 2035-08-06

F1 · security: On August 6, 2025 (the "Grant Date"), the Reporting Person was granted an option to purchase 1,790,000 shares of the Issuer's common stock pursuant to the Issuer's 2021 Equity Incentive Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

F1 · kind: On August 6, 2025 (the "Grant Date"), the Reporting Person was granted an option to purchase 1,790,000 shares of the Issuer's common stock pursuant to the Issuer's 2021 Equity Incentive Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

F1 · derivative.exercise_date: On August 6, 2025 (the "Grant Date"), the Reporting Person was granted an option to purchase 1,790,000 shares of the Issuer's common stock pursuant to the Issuer's 2021 Equity Incentive Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

SEC source: 0001161697-25-000225 · form_4.xml · derivative · entry 6

ERICKSON RONALD P · CIK 0001140319 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · .

Disclosed balance after: 0

Underlying: Common Stock · 16,916 shares

Expires not disclosed

F3 · derivative.exercise_price: On the Grant Date, the Issuer redeemed 16,916 shares of Series H Convertible Preferred Stock held by J3E2A2Z (as defined below) for a combination of cash and common stock at a redemption price equal to the stated value of $70, plus all accrued and unpaid dividends in an amount of $140,210.15, resulting in (i) a cash payment to J3E2A2Z of $654,276.15 in the aggregate and (ii) the issuance to J3E2A2Z of 2,000,000 shares of common stock in the aggregate, at a conversion price of $0.335 per share.

F3 · kind: On the Grant Date, the Issuer redeemed 16,916 shares of Series H Convertible Preferred Stock held by J3E2A2Z (as defined below) for a combination of cash and common stock at a redemption price equal to the stated value of $70, plus all accrued and unpaid dividends in an amount of $140,210.15, resulting in (i) a cash payment to J3E2A2Z of $654,276.15 in the aggregate and (ii) the issuance to J3E2A2Z of 2,000,000 shares of common stock in the aggregate, at a conversion price of $0.335 per share.

F3 · price: On the Grant Date, the Issuer redeemed 16,916 shares of Series H Convertible Preferred Stock held by J3E2A2Z (as defined below) for a combination of cash and common stock at a redemption price equal to the stated value of $70, plus all accrued and unpaid dividends in an amount of $140,210.15, resulting in (i) a cash payment to J3E2A2Z of $654,276.15 in the aggregate and (ii) the issuance to J3E2A2Z of 2,000,000 shares of common stock in the aggregate, at a conversion price of $0.335 per share.

F3 · derivative.exercise_date: On the Grant Date, the Issuer redeemed 16,916 shares of Series H Convertible Preferred Stock held by J3E2A2Z (as defined below) for a combination of cash and common stock at a redemption price equal to the stated value of $70, plus all accrued and unpaid dividends in an amount of $140,210.15, resulting in (i) a cash payment to J3E2A2Z of $654,276.15 in the aggregate and (ii) the issuance to J3E2A2Z of 2,000,000 shares of common stock in the aggregate, at a conversion price of $0.335 per share.

F3 · derivative.expiration_date: On the Grant Date, the Issuer redeemed 16,916 shares of Series H Convertible Preferred Stock held by J3E2A2Z (as defined below) for a combination of cash and common stock at a redemption price equal to the stated value of $70, plus all accrued and unpaid dividends in an amount of $140,210.15, resulting in (i) a cash payment to J3E2A2Z of $654,276.15 in the aggregate and (ii) the issuance to J3E2A2Z of 2,000,000 shares of common stock in the aggregate, at a conversion price of $0.335 per share.

F4 · ownership.nature: Held by J3E2A2Z Limited Partnership ("J3E2A2Z"), an entity affiliated with Ronald P. Erickson.

SEC source: 0001161697-25-000225 · form_4.xml · nonDerivative · entry 2

ERICKSON RONALD P · CIK 0001140319 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · .

Disclosed balance after: 2,000,000

F3 · kind: On the Grant Date, the Issuer redeemed 16,916 shares of Series H Convertible Preferred Stock held by J3E2A2Z (as defined below) for a combination of cash and common stock at a redemption price equal to the stated value of $70, plus all accrued and unpaid dividends in an amount of $140,210.15, resulting in (i) a cash payment to J3E2A2Z of $654,276.15 in the aggregate and (ii) the issuance to J3E2A2Z of 2,000,000 shares of common stock in the aggregate, at a conversion price of $0.335 per share.

F3 · price: On the Grant Date, the Issuer redeemed 16,916 shares of Series H Convertible Preferred Stock held by J3E2A2Z (as defined below) for a combination of cash and common stock at a redemption price equal to the stated value of $70, plus all accrued and unpaid dividends in an amount of $140,210.15, resulting in (i) a cash payment to J3E2A2Z of $654,276.15 in the aggregate and (ii) the issuance to J3E2A2Z of 2,000,000 shares of common stock in the aggregate, at a conversion price of $0.335 per share.

F4 · ownership.nature: Held by J3E2A2Z Limited Partnership ("J3E2A2Z"), an entity affiliated with Ronald P. Erickson.

SEC source: 0001161697-25-000225 · form_4.xml · nonDerivative · entry 1

ERICKSON RONALD P · CIK 0001140319 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 472,202

F1 · price: On August 6, 2025 (the "Grant Date"), the Reporting Person was awarded 335,000 shares of common stock of the Issuer, 50% of which is fully vested on the Grant Date and the remainder of which (the "restricted shares") will vest in 8 quarterly installments with the first two installments vesting six months after the Grant Date. The restricted shares vest in full in the event of a sale of all or substantially all of the Company's sensor related intellectual property or an involuntary termination of Mr. Erickson's employment.

F2 · balance_after: Includes unvested restricted shares.

SEC source: 0001161697-25-000281 · form4.xml · derivative · entry 1

Jenkinson Linda · CIK 0002081130 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,760,000

Underlying: Common Stock · 4,760,000 shares

Expires 2035-08-06

F1 · security: On August 6, 2025 (the "Grant Date"), the Reporting Person was granted an option to purchase 4,760,000 shares of the Issuer's common stock pursuant to the Issuer's 2021 Equity Incentive Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

F1 · kind: On August 6, 2025 (the "Grant Date"), the Reporting Person was granted an option to purchase 4,760,000 shares of the Issuer's common stock pursuant to the Issuer's 2021 Equity Incentive Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

F1 · derivative.exercise_date: On August 6, 2025 (the "Grant Date"), the Reporting Person was granted an option to purchase 4,760,000 shares of the Issuer's common stock pursuant to the Issuer's 2021 Equity Incentive Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

SEC source: 0001161697-25-000277 · form4.xml · derivative · entry 1

Chapman Kirk · CIK 0002080978 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,140,000

Underlying: Common Stock · 7,140,000 shares

Expires 2035-08-06

F1 · security: On August 6, 2025 (the "Grant Date"), the Reporting Person was granted an option to purchase 7,140,000 shares of the Issuer's common stock pursuant to the Issuer's 2021 Equity Incentive Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

F1 · kind: On August 6, 2025 (the "Grant Date"), the Reporting Person was granted an option to purchase 7,140,000 shares of the Issuer's common stock pursuant to the Issuer's 2021 Equity Incentive Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

F1 · derivative.exercise_date: On August 6, 2025 (the "Grant Date"), the Reporting Person was granted an option to purchase 7,140,000 shares of the Issuer's common stock pursuant to the Issuer's 2021 Equity Incentive Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.

SEC source: 0001161697-25-000223 · form4.xml · nonDerivative · entry 1

Conley Peter J · CIK 0001931532 · Former Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Prestwick Associates LLC

Disclosed balance after: 157,750

SEC source: 0001161697-25-000181 · form_4.xml · derivative · entry 5

ERICKSON RONALD P · CIK 0001140319 · Director · CEO · Chairman

10b5-1 filing: No plan indicated

Ownership: Indirect · .

Disclosed balance after: 16,916

Underlying: Common Stock · 16,916 shares

Expires not disclosed

F3 · derivative.exercise_price: Shares of Series H Convertible Preferred Stock were issued pursuant to a Promissory Note Conversion Agreement dated 06/02/2025, whereby J3E2A2Z LP, holder of two convertible redeemable promissory notes, converted $1,184,066 in debt owed. J3E2A2Z received one share of Series H Convertible Preferred Stock for every $70 in principal converted. The Series H Convertible Preferred Stock is convertible into common stock at an initial conversion price of $0.335 per share, subject to potential future adjustment.

F3 · kind: Shares of Series H Convertible Preferred Stock were issued pursuant to a Promissory Note Conversion Agreement dated 06/02/2025, whereby J3E2A2Z LP, holder of two convertible redeemable promissory notes, converted $1,184,066 in debt owed. J3E2A2Z received one share of Series H Convertible Preferred Stock for every $70 in principal converted. The Series H Convertible Preferred Stock is convertible into common stock at an initial conversion price of $0.335 per share, subject to potential future adjustment.

F3 · price: Shares of Series H Convertible Preferred Stock were issued pursuant to a Promissory Note Conversion Agreement dated 06/02/2025, whereby J3E2A2Z LP, holder of two convertible redeemable promissory notes, converted $1,184,066 in debt owed. J3E2A2Z received one share of Series H Convertible Preferred Stock for every $70 in principal converted. The Series H Convertible Preferred Stock is convertible into common stock at an initial conversion price of $0.335 per share, subject to potential future adjustment.

F3 · derivative.exercise_date: Shares of Series H Convertible Preferred Stock were issued pursuant to a Promissory Note Conversion Agreement dated 06/02/2025, whereby J3E2A2Z LP, holder of two convertible redeemable promissory notes, converted $1,184,066 in debt owed. J3E2A2Z received one share of Series H Convertible Preferred Stock for every $70 in principal converted. The Series H Convertible Preferred Stock is convertible into common stock at an initial conversion price of $0.335 per share, subject to potential future adjustment.

F3 · derivative.expiration_date: Shares of Series H Convertible Preferred Stock were issued pursuant to a Promissory Note Conversion Agreement dated 06/02/2025, whereby J3E2A2Z LP, holder of two convertible redeemable promissory notes, converted $1,184,066 in debt owed. J3E2A2Z received one share of Series H Convertible Preferred Stock for every $70 in principal converted. The Series H Convertible Preferred Stock is convertible into common stock at an initial conversion price of $0.335 per share, subject to potential future adjustment.

F2 · ownership.nature: Held by J3E2A2Z Limited Partnership, an entity affiliated with Ronald P. Erickson.

SEC source: 0001161697-25-000163 · form4.xml · nonDerivative · entry 1

Ellingson Larry K · CIK 0002000560 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,404

SEC source: 0001161697-25-000167 · form_4.xml · nonDerivative · entry 1

Takesako Ichiro John Paul · CIK 0001572834 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,875

SEC source: 0001161697-25-000166 · form_4.xml · nonDerivative · entry 1

PEPPER JON · CIK 0001484963 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,850

SEC source: 0001161697-25-000161 · form4.xml · nonDerivative · entry 1

Conley Peter J · CIK 0001931532 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Prestwick Associates LLC

Disclosed balance after: 50,250

SEC source: 0001161697-25-000164 · form_4.xml · nonDerivative · entry 1

ERICKSON RONALD P · CIK 0001140319 · Director · CEO · Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,202

SEC source: 0001161697-25-000165 · form4.xml · nonDerivative · entry 1

OWENS WILLIAM ARTHUR · CIK 0001184212 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,692

SEC source: 0001161697-25-000162 · form4.xml · nonDerivative · entry 2

Cronin John E · CIK 0001543108 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · ipCapital Group, Inc.

Disclosed balance after: 25,000

SEC source: 0001161697-25-000162 · form4.xml · nonDerivative · entry 1

Cronin John E · CIK 0001543108 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,404

SEC source: 0001161697-24-000388 · form4.xml · derivative · entry 5

Cronin John E · CIK 0001543108 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common Stock · 1,000,000 shares

Expires 2029-09-11

F1 · derivative.exercise_date: The option becomes exercisable ratably over a four-year period from the date of grant.

SEC source: 0001161697-24-000429 · form4.xml · derivative · entry 5

Cronin John E · CIK 0001543108 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common Stock · 1,000,000 shares

Expires 2029-09-11

F1 · derivative.exercise_date: The option becomes exercisable ratably over a four-year period from the date of grant.

SEC source: 0001161697-24-000241 · form_4.xml · nonDerivative · entry 1

PEPPER JON · CIK 0001484963 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 514,000

SEC source: 0001161697-24-000074 · form4.xml · derivative · entry 5

OWENS WILLIAM ARTHUR · CIK 0001184212 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2029-02-08

F1 · derivative.exercise_date: Option shares vest immediately.

SEC source: 0001161697-24-000074 · form4.xml · nonDerivative · entry 1

OWENS WILLIAM ARTHUR · CIK 0001184212 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 947,703

SEC source: 0001161697-24-000072 · form4.xml · derivative · entry 2

Londergan Timothy M · CIK 0002001779 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 290,411

Underlying: Common Stock · 290,411 shares

Expires 2029-02-08

SEC source: 0001161697-24-000072 · form4.xml · nonDerivative · entry 1

Londergan Timothy M · CIK 0002001779 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,164

SEC source: 0001161697-24-000070 · form4.xml · derivative · entry 3

Ellingson Larry K · CIK 0002000560 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 290,411

Underlying: Common Stock · 290,411 shares

Expires 2029-02-08

SEC source: 0001161697-24-000070 · form4.xml · nonDerivative · entry 1

Ellingson Larry K · CIK 0002000560 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,164

SEC source: 0001161697-24-000068 · form_4.xml · derivative · entry 7

PEPPER JON · CIK 0001484963 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2029-02-08

F1 · derivative.exercise_date: Option shares vest immediately.

SEC source: 0001161697-24-000068 · form_4.xml · nonDerivative · entry 1

PEPPER JON · CIK 0001484963 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 528,000

SEC source: 0001161697-24-000066 · form4.xml · derivative · entry 4

Cronin John E · CIK 0001543108 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 290,411

Underlying: Common Stock · 290,411 shares

Expires 2029-02-08

SEC source: 0001161697-24-000066 · form4.xml · nonDerivative · entry 1

Cronin John E · CIK 0001543108 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,164

SEC source: 0001161697-24-000064 · form_4.xml · derivative · entry 7

Takesako Ichiro John Paul · CIK 0001572834 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2029-02-08

F1 · derivative.exercise_date: Option shares vest immediately.